10-Q: Tootsie Roll Q3 Earnings Rise Amid Sales Growth, Higher Costs

Tootsie Roll Industries reported an 8.6% increase in third-quarter net earnings, driven by higher domestic sales and investment income, despite rising input costs and increased operating expenses.

Summary

• Net earnings attributable to Tootsie Roll Industries, Inc. increased by 8.6% to $35,659 thousand for the third quarter ended September 30, 2025, compared to $32,844 thousand in the prior year.
• Diluted earnings per share rose to $0.49 in Q3 2025 from $0.45 in Q3 2024, an 8.9% increase.
• Year-to-date net earnings attributable to Tootsie Roll Industries, Inc. increased by 10.8% to $71,261 thousand, with EPS rising to $0.98 from $0.87.
• Net product sales for the third quarter increased by 3.0% to $230,614 thousand, primarily driven by a 3.8% increase in domestic sales.
• Foreign net product sales decreased by 6.1% in the third quarter and 12.2% year-to-date.
• Gross profit margins improved year-to-date, benefiting from higher price realization, plant manufacturing efficiencies, and cost reductions.
• Other income, net significantly increased to $16,233 thousand in Q3 2025 from $7,188 thousand in Q3 2024, partly due to a $4,495 thousand pre-tax out-of-period adjustment for under-recognized bond discount accretion and higher interest income.
• Cash flows from operating activities decreased by $12,814 thousand year-to-date, primarily due to changes in working capital management.
• The company is undertaking a plant expansion project estimated to cost $75,000 to $85,000 thousand over five years, with most capital expenditures expected in 2026 and 2027, to be funded internally.
• The multi-employer pension plan remains in 'critical status' despite receiving $3.4 billion in Special Financial Assistance in July 2024, with ongoing uncertainty regarding its long-term solvency and the company's potential withdrawal liability.

Sentiment

Score: 7

Explanation: The company demonstrated solid earnings and EPS growth, driven by domestic sales and effective margin management, despite rising input costs and increased operating expenses. Strategic investments in plant expansion are positive for the long term. However, significant risks remain from volatile commodity prices (cocoa), potential tariff impacts, and the ongoing uncertainty surrounding the multi-employer pension plan, warranting a moderately positive but cautious outlook.

Positives

• Net earnings attributable to Tootsie Roll Industries, Inc. increased by 8.6% to $35,659 thousand in Q3 2025 and 10.8% to $71,261 thousand year-to-date.
• Diluted earnings per share increased by 8.9% to $0.49 in Q3 2025 and 12.6% to $0.98 year-to-date.
• Domestic net product sales increased by 3.8% in Q3 2025 and 2.4% year-to-date, driven by successful marketing and sales programs.
• Year-to-date product gross profit margins improved to 65.2% of net product sales in 2025 from 66.8% in 2024, benefiting from price increases and manufacturing efficiencies.
• Other income, net saw a substantial increase, partly due to higher interest rates and a $4,495 thousand pre-tax out-of-period adjustment for bond discount accretion.
• Average shares outstanding decreased due to share repurchases, contributing to higher earnings per share.

Negatives

• Earnings from operations decreased by 8.2% to $32,367 thousand in Q3 2025 compared to Q3 2024, primarily due to higher selling, marketing, and administrative expenses.
• Selling, marketing and administrative expenses increased by 12.4% in Q3 2025 and 4.3% year-to-date, reflecting higher advertising, wages, salaries, and benefits.
• Foreign net product sales decreased by 6.1% in Q3 2025 and 12.2% year-to-date.
• Cash flows provided by operating activities decreased by $12,814 thousand year-to-date, attributed to changes in working capital management.
• Cash flows used in investing activities increased unfavorably by $59,667 thousand year-to-date, mainly due to increased purchases of available-for-sale securities and higher capital expenditures.
• The effective income tax rate increased to 26.7% in Q3 2025 and 27.2% year-to-date, partly due to certain deferred compensation not being tax-deductible.

Risks

• Significantly elevated and volatile cocoa and chocolate prices, with older supply contracts expiring in early 2025 leading to higher costs expected in Q4 2025 and into 2026.
• Potential adverse effects from U.S. tariffs and possible retaliatory tariffs on foreign-sourced ingredients, packaging materials, supplies, and manufacturing equipment, estimated at $6,900 thousand annually.
• Uncertainty regarding the long-term solvency of the multi-employer pension plan and the potential for a higher withdrawal liability, despite receiving $3.4 billion in Special Financial Assistance.
• Increasing consumer resistance to higher prices, which could adversely affect sales.
• Continued developments in food industry legislation and regulatory requirements, such as the FDA's intent to phase out petroleum-based synthetic dyes, could adversely affect business and operating results.
• The company's reliance on the Last-In-First-Out (LIFO) inventory method, which results in lower current net earnings and higher income taxes during periods of increasing costs and inflation.

Future Outlook

The company expects continued higher costs for certain ingredients, particularly cocoa and chocolate, in the fourth quarter of 2025 and into 2026, as older, lower-priced supply contracts have expired. A plant expansion project, costing an estimated $75,000 to $85,000 thousand, is planned over the next five years, with most capital expenditures in 2026 and 2027, to meet forecasted demand and improve efficiencies. The company is assessing the implications of the newly signed One Big Beautiful Bill Act (OBBBA) on its operations and financial statements. Management is also monitoring the FDA's intent to phase out petroleum-based synthetic dyes and related state legislation, which could impact product formulations and sales.

Management Comments

• Successful marketing and sales programs contributed to higher domestic sales in Q3 2025.
• The company continued to face challenges in nine months 2025 as customers and consumers became more resistant to higher prices.
• Implemented price increases to mitigate input cost increases and restore margin declines, making progress in Q3 and YTD 2025.
• Mindful of the effects and limits when passing on higher input costs to customers and final consumers.
• The company is focused on the longer term and is continuing to make investments in plant manufacturing operations to meet new consumer and customer product demands, achieve product quality improvements, expand capacity, and increase operational efficiencies.

Industry Context

The consumer products industry, including confectionery, continues to grapple with increasing input costs, particularly for key ingredients like cocoa and chocolate, which are at significantly elevated and volatile levels. This trend has led many companies, including Tootsie Roll, to implement price increases to restore margins. The industry is also facing evolving regulatory landscapes, such as the FDA's proposed phase-out of petroleum-based synthetic dyes, which could necessitate product reformulations and impact consumer preferences. The company's domestic sales growth aligns with a focus on core markets, while foreign sales declines may reflect broader economic or competitive pressures in international markets.

Stakeholder Impact

• Shareholders: Benefited from increased net earnings and EPS, as well as ongoing share repurchases and cash dividends.
• Employees: Certain union employees are impacted by the multi-employer pension plan's critical status and the ongoing uncertainty regarding its long-term solvency and withdrawal liability. Higher wages, salaries, and benefits contributed to increased administrative expenses.
• Customers: Faced with higher product prices due to the company's efforts to restore margins in response to rising input costs.
• Consumers: May experience higher prices and potential changes in product formulations due to new regulations regarding synthetic dyes.
• Suppliers: The company is entering into longer-range supply contracts for cocoa and chocolate at significantly higher costs, impacting these suppliers.

Next Steps

• Continue plant expansion project over the next five years, with most capital expenditures in 2026 and 2027.
• Monitor and evaluate the potential effects of the One Big Beautiful Bill Act (OBBBA) on operations and financial statements.
• Assess the implications of the FDA's intent to phase out petroleum-based synthetic dyes and related state legislation.
• Manage the impact of significantly higher cocoa and chocolate costs as new supply contracts take effect in Q4 2025 and into 2026.
• Continue to monitor and potentially adjust pricing strategies to mitigate input cost increases while being mindful of consumer resistance.

Key Dates

Recommendation

The company delivered strong Q3 and YTD earnings growth, driven by domestic sales and improved gross margins, which are positive indicators. Strategic investments in plant expansion signal a commitment to future growth and efficiency. However, significant headwinds persist, including unprecedented volatility and elevated costs for key raw materials like cocoa and chocolate, the potential adverse impact of tariffs, and the long-term uncertainty surrounding the multi-employer pension plan's solvency and the company's withdrawal liability. These risks, coupled with increased operating expenses and a decline in cash flow from operations, suggest a 'hold' recommendation. While the company is performing well in some areas, the material risks and uncertainties warrant a cautious approach, advising investors to monitor these factors closely before making further investment decisions.

Keywords

Tootsie Roll, TR, confectionery, candy, Q3 2025 earnings, financial results, SEC filing, 10-Q, consumer goods, food industry, tariffs, cocoa prices, pension liability, plant expansion, operating income, net sales